Showing 1 - 6 results of 6 for search 'Elena M SLONIMSKAYA', query time: 0.03s Refine Results
  1. 1
    Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy——
AKT/m-TOR Pathway and Resistance to Cancer Therapy

    Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy——
AKT/m-TOR Pathway and Resistance to Cancer Therapy by Liudmila V SPIRINA, Irina V KONDAKOVA, Natalia V TARASENKO, Elena M SLONIMSKAYA, Evgeny A USYNIN, Alexey K GORBUNOV, Zahar A YURMAZOV, Svetlana Yu CHIGEVSKAYA

    Published 2018-01-01
    Get full text
    Article
  2. 2
    Amplifications of Stemness Gene Loci—New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study

    Amplifications of Stemness Gene Loci—New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study by Nikolai V. Litviakov, Marina K. Ibragimova, Matvey M. Tsyganov, Polina V. Kazantseva, Artem V. Doroshenko, Eugeniy Yu. Garbukov, Irina G. Frolova, Elena M. Slonimskaya

    Published 2021-05-01
    Get full text
    Article
  3. 3
    DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease

    DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease by Matvey M. Tsyganov, Marina K. Ibragimova, Kseniya A. Gaptulbarova, Irina A. Tsydenova, Daria S. Dolgasheva, Evgeniy Y. Garbukov, Anastasia A. Frolova, Elena M. Slonimskaya, Nikolai V. Litvyakov

    Published 2022-04-01
    Get full text
    Article
  4. 4
    Proteasome functioning in breast cancer: connection with clinical-pathological factors.

    Proteasome functioning in breast cancer: connection with clinical-pathological factors. by Elena E Shashova, Yulia V Lyupina, Svetlana A Glushchenko, Elena M Slonimskaya, Olga V Savenkova, Alexey M Kulikov, Nikolay G Gornostaev, Irina V Kondakova, Natalia P Sharova

    Published 2014-01-01
    Get full text
    Article
  5. 5
    Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer

    Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer by Evgeniya V. Kaigorodova, Olga E. Savelieva, Liubov A. Tashireva, Natalia A. Tarabanovskaya, Elena I. Simolina, Evgeny V. Denisov, Elena M. Slonimskaya, Evgeny L. Choynzonov, Vladimir M. Perelmuter

    Published 2018-03-01
    Get full text
    Article
  6. 6
    Predictive and Prognostic Significance of mRNA Expression and DNA Copies Aberrations of <i>ERCC1</i>, <i>RRM1</i>, <i>TOP1</i>, <i>TOP2A</i>, <i>TUBB3</i>, <i>TYMS</i>, and <i>GSTP1</i> Genes in Patients with Breast Cancer

    Predictive and Prognostic Significance of mRNA Expression and DNA Copies Aberrations of <i>ERCC1</i>, <i>RRM1</i>, <i>TOP1</i>, <i>TOP2A</i>, <i>TUBB3</i>, <i>TYMS</i>, and <i>GSTP... by Matvey M. Tsyganov, Marina K. Ibragimova, Evgeniy Yu. Garbukov, Irina A. Tsydenova, Kseniya A. Gaptulbarova, Daria S. Dolgasheva, Ekaterina A. Zdereva, Anastasia A. Frolova, Elena M. Slonimskaya, Nikolai V. Litviakov

    Published 2022-02-01
    Get full text
    Article

Search Tools: